157 related articles for article (PubMed ID: 38792805)
1. The Effect of Low HBV-DNA Viral Load on Recurrence in Hepatocellular Carcinoma Patients Who Underwent Primary Locoregional Treatment and the Development of a Nomogram Prediction Model.
Xiong Y; Wang Z; Liu J; Li K; Zhang Y
Microorganisms; 2024 May; 12(5):. PubMed ID: 38792805
[TBL] [Abstract][Full Text] [Related]
2. Construction and validation of a machine learning-based nomogram to predict the prognosis of HBV associated hepatocellular carcinoma patients with high levels of hepatitis B surface antigen in primary local treatment: a multicenter study.
Xiong Y; Qiao W; Wang Q; Li K; Jin R; Zhang Y
Front Immunol; 2024; 15():1357496. PubMed ID: 38601167
[TBL] [Abstract][Full Text] [Related]
3. Incorporating Inflammatory Markers and Clinical Indicators into a Predictive Model of Single Small Hepatocellular Carcinoma Recurrence After Primary Locoregional Treatments.
Qiao W; Xiong Y; Li K; Jin R; Zhang Y
J Hepatocell Carcinoma; 2024; 11():1113-1125. PubMed ID: 38887683
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments.
Sun Y; Xiong Y; Wang Q; Qiao W; Zhang H; Zhang Y
Front Oncol; 2023; 13():1206345. PubMed ID: 37700838
[TBL] [Abstract][Full Text] [Related]
5. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
Front Oncol; 2021; 11():742630. PubMed ID: 34745962
[TBL] [Abstract][Full Text] [Related]
6. Nomogram built based on machine learning to predict recurrence in early-stage hepatocellular carcinoma patients treated with ablation.
Zhang H; Sheng S; Qiao W; Sun Y; Jin R
Front Oncol; 2024; 14():1395329. PubMed ID: 38800405
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation.
Qiao W; Li J; Wang Q; Jin R; Zhang H
J Hepatocell Carcinoma; 2024; 11():271-284. PubMed ID: 38333222
[TBL] [Abstract][Full Text] [Related]
8. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Nomogram to Predict the Recurrence of HCC Patients Undergoing CECT After Ablation.
Qiao W; Fan Z; Wang Q; Jin R; Hu C
J Hepatocell Carcinoma; 2024; 11():65-79. PubMed ID: 38235069
[TBL] [Abstract][Full Text] [Related]
10. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
Front Oncol; 2022; 12():946531. PubMed ID: 35936698
[TBL] [Abstract][Full Text] [Related]
11. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
[No Abstract] [Full Text] [Related]
12. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma.
Tan J; Yu Y; Lin X; He Y; Jin W; Qian H; Li Y; Xu X; Zhao Y; Ning J; Zhang Z; Chen J; Wu X
Hepatol Int; 2024 Apr; 18(2):550-567. PubMed ID: 37067674
[TBL] [Abstract][Full Text] [Related]
13. Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
Yang C; Wang H; Liu J; Yang F; Lv L; Jiang Y; Cai Q
Front Oncol; 2023; 13():1134933. PubMed ID: 37124520
[TBL] [Abstract][Full Text] [Related]
14. A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics.
Zhang M; Wang Q; Zhang G; Li G; Jin R; Xing H
Front Pharmacol; 2024; 15():1360478. PubMed ID: 38434702
[No Abstract] [Full Text] [Related]
15. Construction and validation of a nomogram for hepatocellular carcinoma patients based on HCC-GRIm score.
Yu X; Yang R; He Z; Li K; Zeng P
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12013-12024. PubMed ID: 37421461
[TBL] [Abstract][Full Text] [Related]
16. Prognostic nomograms for HBV-related BCLC 0-a stage hepatocellular carcinoma incorporating aspartate aminotransferase to albumin ratio.
Wu Y; Peng W; Shen J; Zhang X; Li C; Wen TF
Scand J Gastroenterol; 2023 Jul; 58(7):789-797. PubMed ID: 36620916
[TBL] [Abstract][Full Text] [Related]
17. Beta2-Microglobulin as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram.
Lin Q; Jiang Z; Mo D; Liu F; Qin Y; Liang Y; Cheng Y; Huang H; Fang M
J Hepatocell Carcinoma; 2023; 10():1813-1825. PubMed ID: 37850078
[TBL] [Abstract][Full Text] [Related]
18. Construction of web
Zhan G; Cao P; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
[TBL] [Abstract][Full Text] [Related]
19. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
[TBL] [Abstract][Full Text] [Related]
20. Machine Learning-Based Nomogram for Predicting Overall Survival in Elderly Patients with Cirrhotic Hepatocellular Carcinoma Undergoing Ablation Therapy.
Qiao W; Sheng S; Li J; Jin R; Hu C
J Hepatocell Carcinoma; 2024; 11():509-523. PubMed ID: 38468611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
